Banco Santander SA (SAN)

6.61
0.06 0.90
NYSE : Financial
Prev Close 6.67
Open 6.59
Day Low/High 6.56 / 6.61
52 Wk Low/High 3.89 / 6.99
Volume 6.98M
Avg Volume 7.92M
Exchange NYSE
Shares Outstanding 14.83B
Market Cap 98.89B
EPS 0.40
Div & Yield 0.28 (4.20%)

Latest News

Nasdaq Set for Record Close While Dow Tumbles on Financials Drop

Nasdaq Set for Record Close While Dow Tumbles on Financials Drop

Goldman Sachs, UnitedHealth lead Dow lower.

Goldman Sachs, UnitedHealth Drag the Dow to Triple-Digit Loss

Goldman Sachs, UnitedHealth Drag the Dow to Triple-Digit Loss

Goldman Sachs, UnitedHealth lead Dow lower.

Sanofi Pasteur Ships First Of Its U.S. Influenza Vaccine Doses For 2017-2018 Season

Sanofi Pasteur Ships First Of Its U.S. Influenza Vaccine Doses For 2017-2018 Season

- Health care providers anticipating initial shipments by early August to kick off influenza immunization season -

Santander And New England Revolution Announce 2017 Santander Soccer Scholars(SM) Program

Santander And New England Revolution Announce 2017 Santander Soccer Scholars(SM) Program

Fourth Annual Sweepstakes Honors Local Students' Dedication in Class and on the Field with New England Revolution VIP Match Day Experience

Sanofi To Acquire Protein Sciences

Sanofi To Acquire Protein Sciences

Tesla's Gigafactory Is Actually a Battleground, Jim Cramer Explains

Tesla's Gigafactory Is Actually a Battleground, Jim Cramer Explains

Here is what you need to know.

Santander Launches Ultimate Cash Back(SM) Credit Card: First Consumer Card To Offer Unlimited 1.5% Cash Back Rewards On All Purchases With No Annual Or Transaction Fees

Santander Launches Ultimate Cash Back(SM) Credit Card: First Consumer Card To Offer Unlimited 1.5% Cash Back Rewards On All Purchases With No Annual Or Transaction Fees

Ultimate Cardholders Will Earn and Save with Cash Back Across All Categories with No Cap

Alnylam And Sanofi Genzyme Report Positive Results From Ongoing Phase 2 Open-Label Extension Study With Investigational RNAi Therapeutic Fitusiran In Patients With Hemophilia A And B With Or Without Inhibitors

Alnylam And Sanofi Genzyme Report Positive Results From Ongoing Phase 2 Open-Label Extension Study With Investigational RNAi Therapeutic Fitusiran In Patients With Hemophilia A And B With Or Without Inhibitors

Alnylam Pharmaceuticals , Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company and Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today new positive results from the ongoing...

These 3 Bank Stocks Are Ready to Skyrocket: Charts

These 3 Bank Stocks Are Ready to Skyrocket: Charts

Charts show where to buy them.

Investors May Still Need to Be Patient With Santander

Investors May Still Need to Be Patient With Santander

The trend is up, but the testing of the 50-day line so much has me a little concerned.

World's Second-Largest Economy's Bad Debt Is an Investment Opportunity

World's Second-Largest Economy's Bad Debt Is an Investment Opportunity

Investors should check for progress on bad debts at next week's meeting of eurozone finance ministers.

Cramer: Here Is Why I Am So Excited About the Turn in Europe

Cramer: Here Is Why I Am So Excited About the Turn in Europe

I bet Italy is now on a growth path that it hasn't seen in ages.

North Korea's Latest Missile Launch Rattles Investors Overseas

North Korea's Latest Missile Launch Rattles Investors Overseas

Investors take a cautious stance.

Rally by Eurozone Banks Still Has Legs

Rally by Eurozone Banks Still Has Legs

The euro area's ongoing recovery is set to benefit its financial institutions.

Santander Names Bank Co-Presidents And Appoints Robert Rubino Head Of Corporate And Commercial Banking

Rubino Brings 25 Years of Experience and Accomplishments in Corporate and Commercial Banking, Corporate Finance and Capital Markets

Tougher Auto-Lending Terms Compound Ford's Self-Driving Problem

Tougher Auto-Lending Terms Compound Ford's Self-Driving Problem

Automakers like Ford and General Motors benefited from falling interest rates after the financial crisis, as consumers snapped up vehicles using cheap loans. Now, borrowing costs are going up.

We Have Crossed the Rubicon. Here's How to Protect Yourself

We Have Crossed the Rubicon. Here's How to Protect Yourself

Global central bankers have taken the world of global finance down a perilous path.

Supreme Courts Rules Against Expanding Debt-Collection Abuse Law in Santander Case

Supreme Courts Rules Against Expanding Debt-Collection Abuse Law in Santander Case

The case was brought against Santander by four Maryland residents who defaulted on car loans.

New Analysis Shows Sanofi's Soliqua® 100/33 Lowered HbA1c By More Than 2 Percent In Patients With Screening Levels Greater Than 9 Percent

- All subgroups treated with Soliqua 100/33 achieved a mean HbA1c of below 7 percent after 30 weeks -